Diabetes

Epidemiology, Pathophysiology and Clinical Management
 
 
CRC Press
  • 1. Auflage
  • |
  • erschienen am 12. Oktober 2020
  • |
  • 154 Seiten
 
E-Book | PDF ohne DRM | Systemvoraussetzungen
978-1-000-19764-8 (ISBN)
 

Diabetes: Epidemiology, Pathophysiology and Clinical Management aims to be the one-stop diabetes book for researchers, scientists and clinicians. It details the epidemiology, causes, molecular mechanisms, molecular markers, available drugs, experimental drugs, treatment modalities, and dietary and lifestyle approaches related to diabetes. It focuses on various molecular aspects of diabetes, and its related co-morbidities. Apart from the drug-based treatment approach based on international guidelines, this book also describes various surgical treatments available for cases of uncontrolled symptomatic diabetes. It also lays emphasis on the future possibilities of different approaches for diabetes management.

Key Features

    • Includes treatment guidelines and approaches to diabetes provided by major global diabetes associations
    • Provides a thorough and comprehensive assimilation of detailed information and updates in the field of diabetes, helpful for researchers, scientists and clinicians
    • Contains a chapter on anti-diabetic drugs, that covers both the commercially approved drugs as well as those that are in various phases of experimental, pre-clinical, and clinical trials
    1. Auflage
    • Englisch
    • Milton
    • |
    • Großbritannien
    Taylor & Francis Ltd
    • Für höhere Schule und Studium
    1 schwarz-weiße und 8 farbige Zeichnungen, 4 schwarz-weiße Tabellen
    • 11,22 MB
    978-1-000-19764-8 (9781000197648)
    weitere Ausgaben werden ermittelt

    Dr. Awanish Kumar

    Presently Dr. Awanish Kumar is working as an Assistant Professor in the Department of Biotechnology, National Institute of Technology, Raipur, India. He has more than 10 years of post Ph.D. research experience in the area of drug discovery and health care. He has obtained his Ph.D. degree from Central Drug Research Institute (CDRI), Lucknow & Jawaharlal Nehru University (JNU), New Delhi, India in 2009. He has done post doctoral study from McGill University, Canada. Dr. Kumar has served various national and international organizations with different academic/research capacities. He has published more than 100 peer reviewed research paper in SCI journals. He is the author of several books and chapters. Currently, he is serving various national institutional committees, scientific society, advisory panel and giving his active contribution in academic and research. Awards and laurels won by Dr. Kumar run into volumes. He is the member of many international professional research societies and reviewer/editorial board member of reputed and refereed journals.

    Dr. Ashwini Kumar

    Dr. Ashwini Kumar did his M.Tech (Biotechnology) from Department of Biotechnology & Medical Engineering, National Institute of Technology Rourkela (Odisha), India. His master's research was focused on obesity checking the effect of flavonoids on the lipid accumulation in adipocytes. He did his PhD under the supervision of Dr. Awanish Kumar from the Department of Biotechnology, National Institute of Technology Raipur (Chhattisgarh), India. The broad area of his doctoral research was formulation of mucoadhesive drug delivery systems. His interest lies in biomaterials and metabolic diseases. He has 14 journal publications and 7 book chapters to his credit. Currently, he is working as a Research Associate in Department of Biochemical Engineering and Biotechnology, Indian Institute of Technology Delhi, India.

    Table of Contents

    Chapter 1 Diabetes Epidemiology-Year 1980 and after

    Chapter 2 Diabetes and Inflammation

    Chapter 3 Insulin Resistance and Glucose Regulation

    Chapter 4 Diabetes: A leading contributor to other disease complications

    Chapter 5 Biomarkers of Diabetes

    Chapter 6 Anti-diabetic drugs

    Chapter 7 Diagnosis and treatment

    Chapter 8 Dietary and lifestyle management of diabetes

    Chapter 9 Future prospects and recommendations

    Dateiformat: PDF
    Kopierschutz: ohne DRM (Digital Rights Management)

    Systemvoraussetzungen:

    Computer (Windows; MacOS X; Linux): Verwenden Sie zum Lesen die kostenlose Software Adobe Reader, Adobe Digital Editions oder einen anderen PDF-Viewer Ihrer Wahl (siehe E-Book Hilfe).

    Tablet/Smartphone (Android; iOS): Installieren Sie die kostenlose App Adobe Digital Editions oder eine andere Lese-App für E-Books (siehe E-Book Hilfe).

    E-Book-Reader: Bookeen, Kobo, Pocketbook, Sony, Tolino u.v.a.m. (nur bedingt: Kindle)

    Das Dateiformat PDF zeigt auf jeder Hardware eine Buchseite stets identisch an. Daher ist eine PDF auch für ein komplexes Layout geeignet, wie es bei Lehr- und Fachbüchern verwendet wird (Bilder, Tabellen, Spalten, Fußnoten). Bei kleinen Displays von E-Readern oder Smartphones sind PDF leider eher nervig, weil zu viel Scrollen notwendig ist. Ein Kopierschutz bzw. Digital Rights Management wird bei diesem E-Book nicht eingesetzt.

    Weitere Informationen finden Sie in unserer E-Book Hilfe.


    Download (sofort verfügbar)

    30,49 €
    inkl. 5% MwSt.
    Download / Einzel-Lizenz
    PDF ohne DRM
    siehe Systemvoraussetzungen
    E-Book bestellen